Electrolyzed / Structured Water
Also known as: Living water, Structured water, Electrolyzed reduced water, Alkaline ionized water, ERW, Activated water, Catholyte
This ingredient is classified as unclassified risk (GIRI score: 4.0/10).
Safety Profile
Known Safety Concerns
- No proven pharmacological activity; disease treatment claims not evidence-based (diabetes, cancer, hypertension); high pH may impair gastric acid/drug absorption; "structured water" claims have no scientific basis
Contraindications
- No proven pharmacological activity; disease treatment claims not evidence-based (diabetes, cancer, hypertension); high pH may impair gastric acid/drug absorption; "structured water" claims have no scientific basis
Interactions
Information not yet available for this ingredient profile.
Evidence and Scientific Findings
Ingredient Overview
Electrolyzed water (EW), marketed as “Living Water” (ცოცხალი წყალი), “Structured Water,” or “Alkaline Ionized Water,” is produced by electrolysis of tap or purified water, generating alkaline catholyte (cathode-side, high pH, mildly reducing) and acidic anolyte (anode-side, low pH, oxidising). Industrial/medical applications of electrolyzed water do exist: anolyte (hypochlorous acid HOCl solution) is a legitimate food-grade disinfectant and wound irrigation solution used in clinical settings. SUPPLEMENT CLAIMS AND EVIDENCE: Products sold as drinkable “Living Water” claim to: cure diseases, alkalise blood, provide antioxidant benefits, increase cellular hydration, treat cancer, and correct “bioelectrical imbalance.” NONE of these claims are supported by credible human clinical evidence. Blood pH is tightly regulated (7.35–7.45) by pulmonary and renal buffering — oral consumption of alkaline water cannot meaningfully alter blood pH. “Structured water” (claimed hexagonally structured H2O clusters) has no scientific basis — water cluster structure is destroyed within picoseconds at physiological temperature. SAFETY CONCERNS: (1) High-pH alkaline water (pH 8–10) may interfere with stomach acid (HCl) — potentially impairing protein digestion and gastric pathogen killing. (2) May interfere with enteric medication dissolution pH requirements. (3) If produced from contaminated tap water, electrolysis does not remove heavy metals, organic chemicals, or pharmaceutical residues. (4) Marketing claims to treat specific diseases (diabetes, hypertension, kidney stones, cancer) without clinical evidence = medical fraud risk. (5) The fundamental scientific claims (“electromagnetic homeostasis,” “bioelectrical correction”) have no scientific basis. GIRI assessment: the product is water with no demonstrated pharmacological activity beyond its constituent minerals. Health claims are not substantiated.
Biological and Chemical Classification
Information not yet available for this ingredient profile.
Mechanism of Action
Information not yet available for this ingredient profile.
Clinical Evidence of Effectiveness
Information not yet available for this ingredient profile.
Pharmacokinetics
Information not yet available for this ingredient profile.
Recommended Dosage
Information not yet available for this ingredient profile.
SETI — Scientific Evidence Transparency Index
Evidence unavailable.
No peer-reviewed studies with traceable links have been retrieved for this ingredient. Use the button below to fetch evidence from PubMed.
Score Transparency
0 of 10 approved references (score saturates at 10). More peer-reviewed studies = stronger evidence base.
Method: Q = number of approved references ÷ 10 (capped at 1.0)
Limited — mostly case reports or animal studies
Method: L = mean study-level weight across approved references. Level 1 (meta-analysis / systematic review) = 1.0; Level 2 (RCT) = 0.8; Level 3 (cohort/case-control) = 0.6; Level 4 (case report) = 0.4; Level 5 (animal / in-vitro) = 0.2.
Mixed or neutral — roughly equal benefit and risk signals
Method: D = (sum of risk-scored references − sum of benefit-scored references) ÷ total evidence score, then scaled from [−1, 1] to [0, 1]. 0.0 = pure benefit; 0.5 = neutral; 1.0 = pure risk.
One or more monitoring-level safety signals active
Method: S = 0.5 (neutral baseline) + sum of active signal severity deltas ÷ 10. Severity deltas: Critical = +2.0, High = +1.5, Moderate = +1.0, Low = +0.5. Capped at 1.0.
Final GIRI Score for Electrolyzed / Structured Water. Risk level thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.
Full methodology & data sources
The GIRI Score is computed entirely from structured data — no editorial scoring or subjective weighting is applied at any step.
- References: Only approved references are counted. Each reference is assigned an evidence level (L1–L5) and a direction (risk / neutral / benefit) by the reference manager or AI classifier.
- Safety Signals: Sourced from regulatory agencies (FDA, EMA, Health Canada, TGA, and others) and pharmacovigilance databases. Only active signals count toward the score.
- Formula version: GIRI Score v3.7.0 — Q × L × D × S × 10.
- Limitations: The score reflects published evidence and recorded signals as of the last update date. It is not a clinical risk assessment and should not replace advice from a qualified healthcare professional.
Risk Level Classification
Based on available regulatory signals and scientific evidence, this ingredient presents a moderate safety concern. Caution is advised, particularly at high doses or in sensitive populations.
0–3.0
3.0–5.5
5.5–7.5
7.5–10
The score pin shows exactly where this ingredient falls on the fixed risk scale.
What drove the Moderate classification for Electrolyzed / Structured Water
A score of 4.0 places this ingredient in the Moderate band. Thresholds: Low 0–3.0 · Moderate 3.0–5.5 · High 5.5–7.5 · Critical 7.5–10.
0 approved references.
Limited — mostly case reports or animal studies (Level 4–5).
Neutral or mixed — benefit and risk signals roughly balanced.
No active signals — S component is at neutral baseline (0.5), contributing no extra risk weight.
No major regulatory restrictions or advisories recorded across monitored jurisdictions (FDA, EMA, Health Canada, TGA, and others).
How are the Low / Moderate / High / Critical thresholds defined?
The four risk levels are fixed score bands. A score is assigned to exactly one level based on where it falls:
| Level | Score | Meaning |
|---|---|---|
| LOW | 0.0 – 2.9 | Sparse or predominantly beneficial evidence. No active safety alerts. |
| MODERATE | 3.0 – 5.4 | Mixed signals — some risk alongside benefit. Caution at high doses or in sensitive groups. |
| HIGH | 5.5 – 7.4 | Multiple studies or regulatory alerts documenting adverse effects. Professional oversight recommended. |
| CRITICAL | 7.5 – 10 | Regulatory restrictions in one or more major jurisdictions. Serious documented harm. Avoid without specialist supervision. |
Thresholds are fixed constants (GIRI_Score_Utils::LEVEL_THRESHOLDS). They do not change per ingredient and are never subject to editorial adjustment.